Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01218347Phase 4Completed
Phase 4, open-label, single-arm trial of rosuvastatin in hypercholesterolemia, sponsored by Seoul National University Hospital. Primary endpoints: Time to Maximum Plasma Concentration at Day 21, Maximum Plasma Concentration at Day 21 and 1 more. Started Oct 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01218347.